Similarly, upregulation of PD-L1 has been found on both endothelial cells and tumor cells following treatment with anti-VEGFR2 therapy (33), which confirms the necessity of combination with anti-angiogenic and immunotherapy. Here, CD274 is linked to neoplasm.